Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -69.75% is 16% above its 5-year average of -83.39%, near the high end of its 5-year range (-193.87%–-43.68%).
As of the fiscal period ended Monday, June 30, 2025. 9.67% below its 12-month average of -63.60%.
Annual fiscal-year return on invested capital; no daily interpolation. Historical series through 2025-06-30.
RETURN ON INVESTED CAPITAL (ROIC)
-69.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-63.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-55.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-83.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-9.67%
CURRENT VS 3Y AVG
-25.06%
CURRENT VS 5Y AVG
+16.36%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.27%
median of 791 covered companies
CURRENT VS SECTOR MEDIAN
-97.76%
vs the sector median at left
Regencell Bioscience Holdings Limited
Market Cap
$3.70B
Return on Invested Capital (ROIC)
-69.75%
TTM Avg
-63.60%
3Y Avg
-55.78%
5Y Avg
-83.39%
Market Cap
$3.55B
Return on Invested Capital (ROIC)
-1.07%
TTM Avg
-9.16%
3Y Avg
-22.10%
5Y Avg
-20.63%
Market Cap
$3.52B
Return on Invested Capital (ROIC)
-12.91%
TTM Avg
-40.91%
3Y Avg
-35.75%
5Y Avg
-31.17%
Market Cap
$3.46B
Return on Invested Capital (ROIC)
-28.15%
TTM Avg
-46.92%
3Y Avg
-38.64%
5Y Avg
-44.96%
Market Cap
$3.46B
Return on Invested Capital (ROIC)
-17.68%
TTM Avg
-22.74%
3Y Avg
-21.16%
5Y Avg
-18.86%
Market Cap
$3.46B
Return on Invested Capital (ROIC)
-35.27%
TTM Avg
-38.13%
3Y Avg
-29.19%
5Y Avg
-24.81%
Market Cap
$3.95B
Return on Invested Capital (ROIC)
3.11%
TTM Avg
1.40%
3Y Avg
0.58%
5Y Avg
2.33%
Market Cap
$3.99B
Return on Invested Capital (ROIC)
-33.87%
TTM Avg
-48.11%
3Y Avg
-42.73%
5Y Avg
-35.85%
Market Cap
$3.41B
Return on Invested Capital (ROIC)
-79.40%
TTM Avg
-65.84%
3Y Avg
-73.62%
5Y Avg
-96.54%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regencell Bioscience Holdings Limited (RGC) | $3.70B | -69.75% | -63.60% | -55.78% | -83.39% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.55B | -1.07% | -9.16% | -22.10% | -20.63% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.52B | -12.91% | -40.91% | -35.75% | -31.17% |
| Celcuity Inc. (CELC)vs › | $3.46B | -28.15% | -46.92% | -38.64% | -44.96% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.46B | -17.68% | -22.74% | -21.16% | -18.86% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.46B | -35.27% | -38.13% | -29.19% | -24.81% |
| ICU Medical, Inc. (ICUI)vs › | $3.95B | 3.11% | 1.40% | 0.58% | 2.33% |
| Relay Therapeutics, Inc. (RLAY)vs › | $3.99B | -33.87% | -48.11% | -42.73% | -35.85% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.41B | -79.40% | -65.84% | -73.62% | -96.54% |
| CareDx, Inc (CDNA)vs › | $3.38B | -0.93% | 1.17% | -16.63% | -13.35% |
ROIC
-69.8%
ROE
-73.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-06-30 | -69.75% |
| 2024-06-30 | -57.45% |
| 2023-06-30 | -52.22% |
| 2022-06-30 | -43.68% |
| 2020-06-30 | -193.87% |
| 2019-06-30 | -160.70% |
